ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy

CONCLUSIONS: This multicentre retrospective observational study of bDMARDs used in the treatment of RA showed that, for all the drugs studied, there was no problem with adherence to treatment but rather a difficulty in maintaining treatment with the same drug over time.PMID:37994874 | DOI:10.1080/03007995.2023.2287600

Source: Current Medical Research and Opinion - November 23, 2023 Category: Research Authors: Fiorenzo Santoleri Ruggero Lasala Paolo Abrate Laura Pestrin Enrico Pasut Germana Modesti Felice Musicco Chiara Fulgenzio Eva Zuzolo Gabriella Pieri Martina Roperti Pietro Gazzola Marco Gambera Isabella Martignoni Valentina Montresor Francesco De Vita Fra Source Type: research